200 related articles for article (PubMed ID: 4930475)
1. Fusaric (5-butylpicolinic) acid, an inhibitor of dopamine beta-hydroxylase, affects serotonin and noradrenaline.
Hidaka H
Nature; 1971 May; 231(5297):54-5. PubMed ID: 4930475
[No Abstract] [Full Text] [Related]
2. Evidence for a peripheral effect of fusaric acid, a dopamine beta-hydroxylase inhibitor, on serotonin metabolism.
Bonnay MM; Guerinot F; Bohuon CJ
Biochem Pharmacol; 1974 Oct; 23(19):2770-3. PubMed ID: 4419680
[No Abstract] [Full Text] [Related]
3. Inhibition of dopamine beta-hydroxylase by fusaric acid (5-butylpicolinic acid) in vitro and in vivo.
Nagatsu T; Hidaka H; Kuzuya H; Takeya K; Umezawa H
Biochem Pharmacol; 1970 Jan; 19(1):35-44. PubMed ID: 5507649
[No Abstract] [Full Text] [Related]
4. Effect of dopamine-beta-hydroxylase inhibitors 1,1-dimethyl-3-phenyl-2-thiourea, fusaric acid and dimethyldithiocarbamate, on the rat brain monoamine content following intraventricular injection of L-dopa.
Vetulani J; Reichenberg K
Biochem Pharmacol; 1973 Jun; 22(11):1263-8. PubMed ID: 4727781
[No Abstract] [Full Text] [Related]
5. Inhibition of serotonin biosynthesis by 6-halotryptophans in vivo.
Peters DA
Biochem Pharmacol; 1971 Jul; 20(7):1413-20. PubMed ID: 5163081
[No Abstract] [Full Text] [Related]
6. Studies on central and peripheral noradrenaline neurons using a new dopamine-(beta)-hydroxylase inhibitor.
Corrodi H; Fuxe K; Hamberger B; Ljungdahl A
Eur J Pharmacol; 1970 Oct; 12(2):145-55. PubMed ID: 5472868
[No Abstract] [Full Text] [Related]
7. Effects of 5-(n-butyl)-picolinamide (SCH 10595), a dopamine-beta-hydroxylase inhibitor, on serotonin and catecholamine metabolites in brain.
Korduba CA; Veals J; Symchowicz S
J Pharmacol Exp Ther; 1974 Sep; 190(3):459-65. PubMed ID: 4413186
[No Abstract] [Full Text] [Related]
8. Effect of fusaric acid on aggression, motor activity, and brain monoamines in mice.
Diringer MN; Kramarcy NR; Brown JW; Thurmond JB
Pharmacol Biochem Behav; 1982 Jan; 16(1):73-9. PubMed ID: 6173886
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic nervous transmission in Parkinson's disease.
Rinne UK; Sonninen V; Riekkinen P; Laaksonen H
Med Biol; 1974 Jun; 52(3):208-17. PubMed ID: 4371255
[No Abstract] [Full Text] [Related]
10. 5-hydroxyindole levels in rat brain after inhibition of dopamine -hydroxylase.
Johnson GA; Kim EG; Boukma SJ
J Pharmacol Exp Ther; 1972 Mar; 180(3):539-46. PubMed ID: 5012781
[No Abstract] [Full Text] [Related]
11. The effect of amantadine on radiolabeled biogenic amines in the rat brain.
Symchowicz S; Korduba CA; Veals J
Eur J Pharmacol; 1973 Feb; 21(2):155-60. PubMed ID: 4696098
[No Abstract] [Full Text] [Related]
12. The effect of dopamine-beta-hydroxylase inhibitors, dimethylphenylthiourea and fusaric acid, on locomotor and exploratory activity, body temperature, and regional distribution of biogenic amines in the rat brain.
Vetulani J; Reichenberg K; wiszniowska G; Marchaj J
Pol J Pharmacol Pharm; 1973; 25(6):559-72. PubMed ID: 4792476
[No Abstract] [Full Text] [Related]
13. The effect of L-dopa on monoamine metabolites in Parkinson's disease.
van Woert MH; Bowers MB
Experientia; 1970; 26(2):161-3. PubMed ID: 5308739
[No Abstract] [Full Text] [Related]
14. Metabolism of norepinephrine, serotonin and dopamine in rat brain with stress.
Bliss EL; Ailion J; Zwanziger J
J Pharmacol Exp Ther; 1968 Nov; 164(1):122-34. PubMed ID: 4387046
[No Abstract] [Full Text] [Related]
15. The balance of biogenic amines as condition for normal behaviour.
Birkmayer W; Danielczyk W; Neumayer E; Riederer P
J Neural Transm; 1972; 33(2):163-78. PubMed ID: 4643007
[No Abstract] [Full Text] [Related]
16. Interaction at the synaptic level of fusaric acid with neurotransmitters.
Fischer HD; Rudolph E; Schmidt J; Hilse H; Oehme P; Piesche L
Acta Biol Med Ger; 1980; 39(8-9):935-40. PubMed ID: 7282224
[TBL] [Abstract][Full Text] [Related]
17. L-DOPA: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice.
Everett GM; Borcherding JW
Science; 1970 May; 168(3933):847-50. PubMed ID: 5444060
[No Abstract] [Full Text] [Related]
18. Monoamine mechanisms in chronic schizophrenia: post-mortem neurochemical findings.
Crow TJ; Baker HF; Cross AJ; Joseph MH; Lofthouse R; Longden A; Owen F; Riley GJ; Glover V; Killpack WS
Br J Psychiatry; 1979 Mar; 134():249-56. PubMed ID: 41609
[TBL] [Abstract][Full Text] [Related]
19. P-chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin.
Sanders-Bush E; Sulser F
J Pharmacol Exp Ther; 1970 Nov; 175(2):419-26. PubMed ID: 5312363
[No Abstract] [Full Text] [Related]
20. METABOLISM OF AMINES IN THE BRAIN OF THE CHICK DURING EMBRYONIC DEVELOPMENT.
BOURNE BB
Life Sci (1962); 1965 Mar; 4():583-91. PubMed ID: 14326248
[No Abstract] [Full Text] [Related]
[Next] [New Search]
